Contact Us
Home  /  News & Insights

News & Insights

What we see, think, and know from years of working at the intersection of distress, leadership, and performance.

Filter by
Recent
Consumer & Retail August 2026
Issue 2: The Fog Machine — How the K-Shaped Economy Hides Future Distress Inside America's Biggest Brands

Issue 2: The Fog Machine — How the K-Shaped Economy Hides Future Distress Inside America's Biggest Brands

Procter & Gamble used to be a proxy for the American consumer. That signal has gone quiet, because the consumer split in two. Inside the K-shaped economy, price papers over an eroding volume base, and the fog is about to lift.

Mike Musso Mike Musso Senior Managing Director
Thought Leadership July 2026
Most Decisions Aren't Fatal. Not Making Them Is.

Most Decisions Aren't Fatal. Not Making Them Is.

Ninety-nine percent of decisions are not fatal. But the refusal to make them often is. In distressed and transitional situations, waiting is often the most expensive decision a company can make.

Shawn Hassel Shawn Hassel Managing Partner
Automotive July 2026
Zero Times a Multiple

Zero Times a Multiple

Zero times any multiple is still zero. In distress, trailing EBITDA is a fiction, and the recovery decision keeps getting anchored to it. Distressed value is not a multiple of what a business just lost; it is the sum of what can still be recovered, lever by lever.

Eric Glover Eric Glover Managing Director
Consumer & Retail June 2026
Issue 1: AI in the Backroom — From Hype to Operations

Issue 1: AI in the Backroom — From Hype to Operations

89% of retail and CPG leaders say AI has helped increase revenue. The real question isn't whether AI works — it's where it actually moves margin. The Backroom Report launches with a look at where the returns justify the spend.

Mike Musso Mike Musso Senior Managing Director
Thought Leadership May 2026
Pharmaceutical Distress Is Different. Here's How to Navigate It.

Pharmaceutical Distress Is Different. Here's How to Navigate It.

The companies that navigate pharma distress aren't always the ones with the best science. They're the ones with the right leadership, engaged boards, and a clear view of their options before a crisis forces the issue.

Thomas Allison Thomas Allison Managing Director
Areté Intelligence May 2026
The Mid-Market AI Playbook Is Missing

The Mid-Market AI Playbook Is Missing

Lumen created $50 million in annual value with AI. Air Canada ended up in a tribunal. The difference wasn't the technology — it was the playbook. Here's the framework mid-market companies actually need.

Spencer Lyon Spencer Lyon Principal